Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme.

ESMO Open · 2017 · PMC5623320 · PMID 29018575

Europe PMC DOI

hedged sentences

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a trend towards significancep=0.08so close (0.05 < p ≤ 0.1)

A trend towards significance (p=0.08) between a good performance status and response to TAS-102 was observed.

also in 2,296 other papers

a trend toward significancep=0.08so close (0.05 < p ≤ 0.1)

In particular, a trend toward significance (p=0.08) between a good performance status and response to TAS-102 was observed as well as a previous response to regorafenib and TAS-102 clinical efficacy (p = 0.008).

also in 3,192 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.